Benchling vs Dotmatics: Platform Scope, Ownership and Lock-In

Benchling and Dotmatics show up on the same shortlists, usually when a biotech or a pharma R&D group has outgrown spreadsheets and a basic notebook. They look similar from a distance, since both sell an electronic lab notebook inside a wider data platform, but they are built and owned differently, and the differences matter more for a ten-year decision than the feature grids do.

This comparison reads each vendor’s own pages as of 12 October 2026 and says plainly where those pages stop. We did not run a hands-on test of either product, so this is an analysis of published material, not a review. G2 and Capterra review pages could not be retrieved for this piece, which means we make no claim about user sentiment.

Platform scope: one product line against a portfolio

Benchling’s pricing page describes a core product suite for R&D work, add-on capabilities, solution accelerators and services, and lists product lines such as Bioresearch, Biologics, Bioprocess, Automation, In Vivo and AI, plus a Validated Cloud option. It is organized as one platform that customers extend.

Dotmatics’ product page tells a different story. It lists Luma as an “AI-native multimodal research platform” with data management, workflow automation and instrument integration, and then a series of named applications: Geneious, SnapGene, Prism, OMIQ, FCS Express, Protein Metrics and others, along with an ELN. Several of these are well-known standalone tools that Dotmatics acquired. The footer also lists LabArchives, which Insightful Science, Dotmatics’ earlier name, announced it had acquired on 10 November 2021.

The practical consequence: with Benchling you mostly buy more of one system. With Dotmatics you may be buying several products with different histories and different interfaces, tied together by Luma. That is a strength if you already use Prism or Geneious, and a risk if you only want a notebook and are asked to adopt a platform.

Compliance claims: what each side actually writes

Both vendors claim the right things. The wording differs.

Benchling’s Validated Cloud page states that customers use e-signature controls per 21 CFR Part 11 and Annex 11, receive controlled quarterly releases, work in a dedicated validated tenant that separates GxP and non-GxP work, and get guidance and documentation for validation including IQ and OQ. It says Benchling can comply with ISO 27001 security standards and align with ISO 9001 quality management guidance, which is not the same as stating a certificate is held.

Dotmatics’ ELN page says FDA 21 CFR Part 11 compliance, electronic signatures and immutable audit trails are built in, and its footer displays ISO 27001 and ISO 9001 certified badges, plus SOC 2 and a GxP badge. The page gives no detail on how the audit trail works, on validation documents, or on the deployment model.

Neither is independent evidence. FDA does not certify software against Part 11, so “compliant” always means “supports compliant use when configured and validated by the user”. The question to ask each vendor is the same:

1. Which release do your validation documents cover, and how do you notify us of changes?
2. Can we audit you as a supplier? EU Annex 11 expects regulated users to be able to assess supplier competence and, where risk requires it, audit.
3. Which controls are on in a standard tenant, and which need a separate regulated offering?

Benchling’s separate validated tenant makes the answer to the third question visible on its page. For Dotmatics, we found no equivalent statement, so ask.

Ownership and what it does to risk

Dotmatics changed owner in 2025. Siemens announced on 1 July 2025 that it had completed the purchase at an enterprise value of 5.1 billion dollars and that Dotmatics would sit in its Digital Industries Software business, extending its product lifecycle management software into life sciences. The release describes how Luma will connect research to production, and does not make a formal commitment about the continuity of individual Dotmatics products. For a deeper reading of what the deal changes, see our analysis of Siemens buying Dotmatics.

The pages we read for Benchling do not discuss ownership. We did not research its investors for this piece, so we say nothing about them, and a buyer should ask.

The balance of risk is not obvious:

• A large strategic owner brings financial depth and a long-term horizon, and it also brings priorities set by an industrial software group, not by life-science buyers.
• A single-product vendor concentrates its engineering on one platform, and it also concentrates your dependency on that vendor.

Neither vendor can be called safer on this evidence. What helps is a change-of-control clause in your contract, which you can request from either.

Lock-in and exit

Lock-in is the part that vendor pages almost never discuss. What we could establish:

• Benchling documents a Data Export tool in its interface and an Exports endpoint in its API; per the SDK documentation, exporting notebook entries starts a long-running task and returns a download link to a ZIP of PDFs. PDFs preserve how an entry looked. They do not necessarily preserve structured entities, links between records or the audit trail as data.
• Dotmatics: the ELN page we read says nothing about export. The Luma platform describes integration with instruments and databases, which is about getting data in, not out.

This is not evidence that either is difficult to leave. It is evidence that the exit path is not described publicly, so it has to be tested. Put it in the proof of concept: export a real project, open it outside the platform, and check what is missing. Our guide to choosing an ELN lists the other questions to settle before signature.

A short test plan that fits either vendor

EU Annex 11, in the text published by the European Commission, gives the regulated user a frame for this. Clause 3.1 asks for formal agreements with service providers that state the provider’s responsibilities. Clause 3.2 says the need for a supplier audit should rest on a risk assessment. Clause 3.4 says supplier quality-system and audit information should be available to inspectors on request. Clause 4.8 says that when data are moved to another format or system, validation should include checks that values and meaning are not altered. Clause 17 says the ability to retrieve archived data should be ensured and tested when the system changes.

Turn that into a short list of tests for the proof of concept:

Annex 11 is an EU text and Part 11 is US law, so a lab under both should map the same tests to each. The point is that the tests are cheap, they can be done before signature, and neither vendor’s public pages answer them for you.

Who should lean which way

Lean toward Benchling if your work is mainly biology or biologics, you want one platform rather than a bundle, and a separate validated tenant for regulated work matches your quality system. The compromise is that all of this is sold by quotation, so you cannot estimate cost without a sales cycle.

Lean toward Dotmatics if you already depend on tools in its portfolio, such as Prism or Geneious, or if your work spans chemistry and biology and you want one vendor for both. The compromise is a more complex product landscape, an owner whose strategy is set by Siemens, and less public detail about validation and export.

For a pharma discovery group choosing among a wider field, our guide to the best drug discovery ELNs puts these two next to alternatives, and the Dotmatics overview goes into the product itself.

The bottom line

Benchling and Dotmatics are closer in ambition than in structure. One is a platform built around biology R&D with a visible regulated option. The other is a portfolio assembled by acquisition, now inside an industrial software group. Both hide prices behind a sales process, both assert compliance in marketing language, and neither describes in public how a customer leaves.

So the decision comes down to three requests you can make this week: the validation package and supplier audit terms, the ownership and change-of-control position, and a tested export of your own data. A vendor that answers all three in writing has earned a place on the final list. The limit of this analysis is that it covers only what the vendors publish, and published pages change often.

This site is editorially independent. Labsoftwareguide.com is not paid by Benchling, Dotmatics or Siemens for placement, favorable coverage, or link inclusion, and no vendor reviewed this piece before publication.

FAQ

Is Benchling or Dotmatics better for a regulated lab?

Neither can be called better from public material alone. Benchling describes a dedicated validated tenant, quarterly releases and IQ/OQ documentation; Dotmatics says Part 11 compliance, electronic signatures and audit trails are built in. Both are vendor claims, so ask each for the validation package and a supplier audit before comparing.

Does Dotmatics own LabArchives?

Insightful Science, the company that later became Dotmatics, announced the acquisition of LabArchives on 10 November 2021, and the Dotmatics site lists LabArchives among its products. Dotmatics has since been bought by Siemens. Confirm with the vendor how the products are packaged and supported today.

Do Benchling and Dotmatics publish their prices?

No. Benchling’s pricing page lists product lines and states that pricing is customized to each organization. Dotmatics’ product pages we read state no prices. Plan for a quotation process in both cases, and compare quotes on the same user count, modules and term.

How hard is it to leave Benchling?

Benchling provides a Data Export tool and an API export for notebook entries that produces PDFs, according to its help material and SDK documentation. Whether that preserves everything you need, such as structured entities and the audit trail, must be tested before signature, not after.

Which one suits a small academic group?

Both are priced by quotation and aimed at organizations, so a small academic group should look at cheaper or open options first. Our guide to academic and research ELNs on this site covers that segment.

Sources

1. EudraLex Volume 4, Annex 11: Computerised Systems (accessed 2026-10-12)
2. Benchling pricing (accessed 2026-10-12)
3. Benchling Validated Cloud (accessed 2026-10-12)
4. Benchling SDK documentation, Export service (accessed 2026-10-12)
5. Dotmatics products (accessed 2026-10-12)
6. Dotmatics Electronic Lab Notebook (accessed 2026-10-12)
7. Siemens completes acquisition of Dotmatics (accessed 2026-10-12)
8. Insightful Science acquires LabArchives to expand its electronic lab notebook portfolio (accessed 2026-10-12)